Skip to main navigation
Skip to main content
Skip to Footer
US
Novartis site directory
Our Products
US Products By Brand
Patient Assistance
Product Portfolio
Our Process
Therapeutic Areas
Product Related Issues
About Us
Novartis US at a Glance
Who We Are
Diversity & Inclusion
Our Leadership
Research
Contact Us
Corporate Responsibility
Novartis in Society US Reports
External Funding
Corporate Citizenship
Business Conduct
Corporate Integrity Agreement
Payments to HCPs & HCOs
Post-Marketing Commitments
Enhanced Verification Request
Beacon of Hope
News
News Archive
Statements
Stories
The STEP Program
US Media Contacts
Novartis US COVID-19 Initiatives
Careers
Careers Search
Working at Novartis
Career Paths
Career Programs
Employee Benefits
Awards & Recognition
NIBR Careers Frequently Asked Questions
Search
News Archive
Advanced Search
Basic Search
From Date:
To Date:
Show:
All
Media Releases
Stories
Filter By
2020
December
Media Release
/
Dec 15, 2020
Novartis announces positive FDA Advisory Committee recommendation for use of Entresto® to treat patients with HFpEF
Read More
Media Release
/
Dec 09, 2020
Novartis Kisqali® demonstrates nearly five years median overall survival in metastatic breast cancer
Read More
Media Release
/
Dec 08, 2020
Novartis investigational STAMP inhibitor asciminib (ABL001) shows superior MMR rate to Bosulif®* in chronic myeloid leukemia trial
Read More
Media Release
/
Dec 07, 2020
Novartis and Amgen partner with Karamo Brown to support and empower people living with migraine
Read More
Media Release
/
Dec 01, 2020
Novartis announces FDA approval of Xolair® (omalizumab) for adults with nasal polyps
Read More
November
Media Release
/
Nov 19, 2020
New data at ASH to reinforce breadth of Novartis hematology portfolio across multiple blood cancers and serious hematologic diseases
Read More
Media Release
/
Nov 13, 2020
New Novartis analyses for investigational inclisiran demonstrate consistently effective and sustained LDL-C reduction at month 17, regardless of age and gender
Read More
Media Release
/
Nov 05, 2020
Novartis Cosentyx® shows early synovitis reduction in patients with psoriatic arthritis in first-of-its-kind study
Read More
October
Media Release
/
Oct 05, 2020
Novartis STEP Program™ awards nearly $375,000 to patient advocacy organizations for their innovative solutions in biomarker testing; now accepting proposals for caregiving in cancer and certain blood disorders
Read More
Media Release
/
Oct 03, 2020
Novartis announces five-year data that reinforce the safety and efficacy profile of Aimovig® (erenumab-aooe) in adult patients with episodic migraine
Read More
Search Results Navigation
First page
« first
Previous page
‹ previous
…
Page
2
of 5
Page
3
of 5
Page
4
of 5
Current page
5
of 5
Page
6
of 5
Next page
next ›
Last page
last »
Share
Twitter
Facebook
LinkedIn
Email
Whatsapp
Jump to Comments
Print
Save
Related Links
News
You are here
Home
›
News